Human BST-1/CD157 protein (Recombinant) (C-His) (STJP002635)

SKU:
STJP002635

£84.50 - £315.50
Current Stock:
Host: HEK293 cells
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Recombinant-Human BST-1/CD157-C-His protein was developed from hek293 cells and has a target region of C-His. For use in research applications.
Formulation: Lyophilized from a 0.2 Mu m filtered solution of PBS, pH7.4.
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: BST1
Gene ID: 683
Uniprot ID: BST1_HUMAN
Immunogen Region: Gly29-Lys292
Immunogen: Recombinant Human BST-1/CD157 Protein is produced by Human Cells expression system. The target protein is expressed with sequence (Gly29-Lys292) of human CD157/BST1/ADP-ribosyl cyclase 2/Cyclic ADP-ribose hydrolase 2 (Accession #Q10588) fused with a
Function Catalyzes both the synthesis of cyclic ADP-beta-D-ribose (cADPR) from NAD(+), and its hydrolysis to ADP-D-ribose (ADPR). Cyclic ADPR is known to serve as an endogenous second messenger that elicits calcium release from intracellular stores, and thus regulates the mobilization of intracellular calcium (Probable). May be involved in pre-B-cell growth (Probable).
Protein Name Adp-Ribosyl Cyclase/Cyclic Adp-Ribose Hydrolase 2
Adp-Ribosyl Cyclase 2
Bone Marrow Stromal Cell Antigen 1
Bst-1
Cyclic Adp-Ribose Hydrolase 2
Cadpr Hydrolase 2
Cd Antigen Cd157
Database Links Reactome: R-HSA-163125
Reactome: R-HSA-196807
Reactome: R-HSA-6798695
Cellular Localisation Cell Membrane
Lipid-Anchor
Gpi-Anchor
Alternative Protein Names Adp-Ribosyl Cyclase/Cyclic Adp-Ribose Hydrolase 2 protein
Adp-Ribosyl Cyclase 2 protein
Bone Marrow Stromal Cell Antigen 1 protein
Bst-1 protein
Cyclic Adp-Ribose Hydrolase 2 protein
Cadpr Hydrolase 2 protein
Cd Antigen Cd157 protein
BST1 protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance